Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Takeda Pharmaceutical
Watchlist
Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?
Equity Bottom-Up
242 Views
15 Sep 2016 23:57
The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Event-Driven
Unpaywalled Insights
Asia Event-Driven
South Korea
Equity Derivatives
Unpaywalled Equity-Bottom-Up
Indonesia Selamat Pagi!
India
Trending Insights
More »
NTT (9432) To Overpay To Take Over NTT Data (9613) Subsidiary?
Laopu Gold (6181 HK): US$300m Primary Placement & Index Inclusion Green Light
CATL (300750 CH): Index Inclusion as Potential Listing Nears
Swire Pac (19 HK): Thai Beverage Spin-Off
Don't Swim Naked: TIME TO PUT YOUR SHORTS ON!
Top Unpaywalled Insights
More »
Our AI-Powered Accounting Risk Trading Strategy Beat the S&P 500 by 2.5x
India-UK Free Trade Agreement: A New Era for India's Textile Industry
The Rise of Quant Investing in Crypto w/ Truvius CEO Connor Farley | The New Barbarians #007
New Research: Unlocking Quantitative Alpha in Cryptocurrency Markets
The Evolution of Portfolio Management: Bridging Traditional Models and Machine Learning
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Okja: The Fight Between Netflix Vs. CJ CGV
05 Jun 2017
Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?
15 Sep 2016
Netflix & Amazon Expand in Korea – Not a Coincidence
20 Jan 2016
Thoughts on Amazon –What Does Its Valuation Tells Us?
01 Dec 2015
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x